T1	Condition 0 2	RA
A1	Optional T1
T2	Drug 21 24	MTX
T3	Multiplier 28 40	stable doses
T4	Multiplier 44 62	10 to 25 mg weekly
T5	Temporal 63 84	for at least 12 weeks
R1	Has_multiplier Arg1:T2 Arg2:T3	
R2	Has_multiplier Arg1:T2 Arg2:T4	
R3	Has_temporal Arg1:T2 Arg2:T5	
T6	Measurement 93 98	DAS28
T7	Value 102 115	3.2 or higher
R4	Has_value Arg1:T6 Arg2:T7	
T8	Non-representable 116 221	(The level of disease activity is considered to be low if the DAS28 is 3.2 or less) (Prevoo et al., 1995)
T9	Condition 223 225	OA
A2	Optional T9
T10	Condition 247 261	osteoarthritis
T11	Observation 262 279	made by physician
R5	Has_context Arg1:T10 Arg2:T11	
T12	Scope 21 221	MTX at stable doses of 10 to 25 mg weekly for at least 12 weeks, Have a DAS28 of 3.2 or higher (The level of disease activity is considered to be low if the DAS28 is 3.2 or less) (Prevoo et al., 1995)
R6	Has_scope Arg1:T1 Arg2:T12	
T13	Scope 247 279	osteoarthritis made by physician
R7	Has_scope Arg1:T9 Arg2:T13	
